EP1636341A4 - Stammzellen für klinische und kommerzielle anwendungen - Google Patents

Stammzellen für klinische und kommerzielle anwendungen

Info

Publication number
EP1636341A4
EP1636341A4 EP04809422A EP04809422A EP1636341A4 EP 1636341 A4 EP1636341 A4 EP 1636341A4 EP 04809422 A EP04809422 A EP 04809422A EP 04809422 A EP04809422 A EP 04809422A EP 1636341 A4 EP1636341 A4 EP 1636341A4
Authority
EP
European Patent Office
Prior art keywords
clinical
stem cells
commercial purposes
commercial
purposes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04809422A
Other languages
English (en)
French (fr)
Other versions
EP1636341A2 (de
Inventor
Liping Tang
Robert H Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/857,443 external-priority patent/US20050014255A1/en
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of EP1636341A2 publication Critical patent/EP1636341A2/de
Publication of EP1636341A4 publication Critical patent/EP1636341A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
EP04809422A 2003-05-29 2004-05-28 Stammzellen für klinische und kommerzielle anwendungen Withdrawn EP1636341A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47402003P 2003-05-29 2003-05-29
US10/857,443 US20050014255A1 (en) 2003-05-29 2004-05-27 Stem cells for clinical and commercial uses
PCT/US2004/017009 WO2005033268A2 (en) 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses

Publications (2)

Publication Number Publication Date
EP1636341A2 EP1636341A2 (de) 2006-03-22
EP1636341A4 true EP1636341A4 (de) 2007-08-01

Family

ID=46123777

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04809422A Withdrawn EP1636341A4 (de) 2003-05-29 2004-05-28 Stammzellen für klinische und kommerzielle anwendungen

Country Status (4)

Country Link
EP (1) EP1636341A4 (de)
JP (1) JP2007525193A (de)
CA (1) CA2527700A1 (de)
WO (1) WO2005033268A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465976B2 (en) 2007-02-12 2013-06-18 Cedars-Sinai Medical Center Methods for isolating and using hematopoietic and embryonic stem cells of the peritoneal cavity
US20100111914A1 (en) 2007-05-21 2010-05-06 Yuanyuan Zhang Stem cells from urine and methods for using the same
KR20100039284A (ko) * 2007-05-21 2010-04-15 웨이크 포리스트 유니버시티 헬스 사이언시즈 소변으로부터의 전구 세포 및 이를 사용하는 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046373A1 (en) * 2000-12-06 2002-06-13 Hariri Robert J Method of collecting placental stem cells
WO2004024957A2 (en) * 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
AU4221399A (en) * 1998-05-29 1999-12-13 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002046373A1 (en) * 2000-12-06 2002-06-13 Hariri Robert J Method of collecting placental stem cells
WO2004024957A2 (en) * 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis

Also Published As

Publication number Publication date
CA2527700A1 (en) 2005-04-14
JP2007525193A (ja) 2007-09-06
WO2005033268A2 (en) 2005-04-14
EP1636341A2 (de) 2006-03-22
WO2005033268A3 (en) 2006-03-23
WO2005033268A9 (en) 2005-09-15
WO2005033268A8 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
EP1809740A4 (de) Herzstammzellen
EP1635858A4 (de) Gezielte abgabe an legumain exprimierende zellen
GB2441530B (en) Stem Cells
DE60319848D1 (de) Medikament mit mesenchym-stammzellen
GB2407821B (en) Stem Cells
EP1543037A4 (de) Potenzierung dentritischer zellen
DE602005018591D1 (de) Sekundärbatterie und herstellungsverfahren dafür
AU2003247514A8 (en) Meningeal-derived stem cells
EP1644135A4 (de) Verbesserte solarzellen
EP1463803A4 (de) Hämatopoetische zellen von menschlichen embryonalen stammzellen
ATE432056T1 (de) Zervikale zwischenwirbelprothese
DE60325132D1 (de) Endoskopische Kapsel
DE602004016157D1 (de) Regenerativer taktzwischenverstärker
DE50313587D1 (de) Sämaschine
DE50306941D1 (de) Bandscheibenprothese
EP1594954A4 (de) Direkte genetische modifikationen menschlicher stammzellen
DE60312451D1 (de) Wiederverschliessbare Packung
DK1576091T3 (da) Human adult olefaktorisk stamcelle
GB2431165B (en) Medium for growing human embryonic stem cells
DE502004009346D1 (de) Sämaschine
DE50303220D1 (de) Sämaschine
EP1636341A4 (de) Stammzellen für klinische und kommerzielle anwendungen
DE502004008433D1 (de) Wägezelle
EP1757277A4 (de) Orale zubereitungen und verfahren zu ihrer herstellung
FI20050953L (fi) Aktiivisen pään sulkimella varustettu keinotekoinen siemen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20051222

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/00 20060101AFI20060427BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070628

17Q First examination report despatched

Effective date: 20080317

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080930